LONDON, 11 July 2022–Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a partnership with Rods&Cones to provide smart surgery glasses and digital remote assistance to customers. By providing customers with smart surgery glasses, Smith+Nephew representatives can ‘see’ through the eyes of the surgeon, instrumentalist nurse, or any healthcare professional using them, enabling continuous remote support before, during, and after surgical interventions.
Initially used in the UK to support the NHS and other customers, this solution allows Smith+Nephew to increase its ability to offer technical support for safe and effective use of its products at the right time from anywhere in the world. The increased complexity of surgery, advancement of technologies, and need for productivity and efficiency is enabled by ensuring a specialist is available remotely to give best possible expertise exactly when they need it, in the least disruptive way.
“I am delighted that we have agreed to partner with one of the most innovative companies in the area of remote surgical support,” said Simon Tarry, Managing Director of Smith+Nephew’s UKI/Nordics region. “This new partnership will enable our team to deliver the highest possible expertise exactly when our customers and patients need it. At the same time, I believe enhancing our ability to support our customers remotely serves patient safety and sustainability to great effect.”
The multi-year agreement with Rods&Cones allows Smith+Nephew to scale its remote support capability for customers, enabling connectivity with specialist surgeons during minimally invasive surgery. The MIS (Minimal Invasive Surgery) Kit connects seamlessly to a secure Rods&Cones Remote Expert interface, which allows the user to follow and attend a surgery just as if standing in the OR, but with the exact view of the surgeon or other healthcare professional.
Bruno Dheedene, CEO and Founding Partner of Rods&Cones stated that:
“We are thrilled to work with such a great company as Smith+Nephew. The achievements they have made in the MedTech industry, especially within the sphere of repair, regeneration and replacement of soft and hard tissue has been awe-inspiring. This partnership between Smith+Nephew and Rods&Cones will be a great step forward and together we will change healthcare for the better.”
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2021. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
Rods&Cones’ purpose is to be a catalyst of change in healthcare to improve people’s lives. The company provides a remote assistance service used to connect medical experts worldwide. With their state-of-the-art technological devices and a digital remote assistance platform, users can connect safely with surgeons, product specialists, or other medical professionals anywhere in the world, in real-time.
Rods&Cones was founded in 2017 by two brothers, Bruno and Jan Dheedene. Based in Amsterdam, The Netherlands, the company has now become a leading international supplier of remote surgical assistance services.
David Snyder | +1 978-749-1440 | Smith+Nephew
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as “aim”, “plan”, “intend”, “anticipate”, “well-placed”, “believe”, “estimate”, “expect”, “target”, “consider” and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: risks related to the impact of COVID-19, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, material delays and cancellations of elective procedures, reduced procedure capacity at medical facilities, restricted access for sales representatives to medical facilities, or our ability to execute business continuity plans as a result of COVID-19; economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers (including, without limitation, as a result of COVID-19); price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of COVID-19); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew’s most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew’s expectations.
Trademark of Smith+Nephew. Certain marks registered US Patent and Trademark Office.